CA125: a novel cardiac biomarker for infants with congenital diaphragmatic hernia

BACKGROUND: The carbohydrate antigen 125 (CA125) was proven as a robust biomarker for risk stratification in adults with heart failure. This is the first study analyzing CA125 in a cohort of infants with congenital diaphragmatic hernia (CDH). METHODS: Sixty-eight infants with CDH, treated at the Uni...

Descripción completa

Detalles Bibliográficos
Autores principales: Schroeder, Lukas, Pugnaloni, Flaminia, Dolscheid-Pommerich, Ramona, Geipel, Annegret, Berg, Christoph, Holdenrieder, Stefan, Mueller, Andreas, Kipfmueller, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2022
Materias:
Clinical Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988682/
https://www.ncbi.nlm.nih.gov/pubmed/35705629
http://dx.doi.org/10.1038/s41390-022-02130-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988682/
https://www.ncbi.nlm.nih.gov/pubmed/35705629
http://dx.doi.org/10.1038/s41390-022-02130-8

Ejemplares similares